NO-HDAC dual inhibitors
Author:
Publisher
Elsevier BV
Subject
Organic Chemistry,Drug Discovery,Pharmacology,General Medicine
Reference247 articles.
1. Polypharmacology: drug discovery for the future;Reddy;Expet Rev. Clin. Pharmacol.,2013
2. Multifunctional drugs: a novel concept for psychopharmacology;Stahl;CNS Spectr.,2009
3. Polypharmacology: challenges and opportunities in drug discovery: miniperspective;Anighoro;J. Med. Chem.,2014
4. From magic bullets to designed multiple ligands;Morphy;Drug Discov. Today,2004
5. Promise and challenges in drug discovery and development of hybrid anticancer drugs;Gediya;Expet Opin. Drug Discov.,2009
Cited by 11 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. In silico Evaluation of NO-Sartans against SARS-CoV-2;Current Drug Discovery Technologies;2024-11
2. Histone deacetylases: Regulation of vascular homeostasis via endothelial cells and vascular smooth muscle cells and the role in vascular pathogenesis;Genes & Diseases;2024-11
3. Design, synthesis and biological evaluation of novel imidazole-based benzamide and hydroxamic acid derivatives as potent histone deacetylase inhibitors and anticancer agents;Journal of Molecular Structure;2024-02
4. A review of recent advances in quinoline/isoquinoline based hybrids as microtubule targeted cancer therapeutics: Synthesis, binding mode, QSAR and docking studies;Journal of Molecular Structure;2024-01
5. Targeting histone deacetylases for cancer therapy: Trends and challenges;Acta Pharmaceutica Sinica B;2023-06
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3